USD 0.17
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 149.72 Thousand USD | 32.74% |
2022 | 112.79 Thousand USD | -18.95% |
2021 | 139.17 Thousand USD | 65.03% |
2020 | 84.33 Thousand USD | -13.54% |
2019 | 97.53 Thousand USD | 68.15% |
2018 | 58 Thousand USD | -12.21% |
2017 | 66.07 Thousand USD | -86.42% |
2016 | 486.45 Thousand USD | 23922.42% |
2015 | 2025.00 USD | 0.0% |
2013 | 18.16 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2007 | 562.07 Thousand USD | -19.67% |
2006 | 699.68 Thousand USD | -28.57% |
2005 | 979.52 Thousand USD | 85.93% |
2004 | 526.83 Thousand USD | 2.14% |
2003 | 515.79 Thousand USD | -77.39% |
2002 | 2.28 Million USD | 341.54% |
2001 | 516.72 Thousand USD | -96.1% |
2000 | 13.23 Million USD | 840426.1% |
1999 | 1575.00 USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 33.42 Thousand USD | 32.79% |
2023 Q2 | 60.25 Thousand USD | 299.62% |
2023 Q4 | 25.16 Thousand USD | -48.87% |
2023 Q1 | 15.07 Thousand USD | 21.81% |
2023 FY | 149.72 Thousand USD | 32.74% |
2023 Q3 | 49.22 Thousand USD | -18.3% |
2022 Q2 | 24.62 Thousand USD | -36.23% |
2022 Q1 | 38.61 Thousand USD | 11.47% |
2022 Q4 | 12.37 Thousand USD | -66.72% |
2022 FY | 112.79 Thousand USD | -18.95% |
2022 Q3 | 37.18 Thousand USD | 51.03% |
2021 FY | 139.17 Thousand USD | 65.03% |
2021 Q3 | 41.35 Thousand USD | 16.53% |
2021 Q2 | 35.48 Thousand USD | 28.13% |
2021 Q4 | 34.63 Thousand USD | -16.23% |
2021 Q1 | 27.69 Thousand USD | 62.21% |
2020 Q1 | 29.58 Thousand USD | 24.09% |
2020 Q3 | 20.08 Thousand USD | 14.2% |
2020 Q4 | 17.07 Thousand USD | -14.99% |
2020 FY | 84.33 Thousand USD | -13.54% |
2020 Q2 | 17.58 Thousand USD | -40.55% |
2019 FY | 97.53 Thousand USD | 68.15% |
2019 Q1 | 30.22 Thousand USD | 53.28% |
2019 Q2 | 21.98 Thousand USD | -27.26% |
2019 Q4 | 23.84 Thousand USD | 11.01% |
2019 Q3 | 21.47 Thousand USD | -2.33% |
2018 Q1 | 3959.71 USD | 0.0% |
2018 Q2 | 6970.20 USD | 76.03% |
2018 Q4 | 19.72 Thousand USD | -27.9% |
2018 Q3 | 27.35 Thousand USD | 292.41% |
2018 FY | 58 Thousand USD | -12.21% |
2017 FY | 66.07 Thousand USD | -86.42% |
2016 FY | 486.45 Thousand USD | 23922.42% |
2015 FY | 2025.00 USD | 0.0% |
2013 FY | 18.16 Thousand USD | 0.0% |
2012 FY | - USD | 0.0% |
2008 Q1 | 107.13 Thousand USD | -12.16% |
2008 Q3 | 111.76 Thousand USD | -8.7% |
2008 Q2 | 122.4 Thousand USD | 14.26% |
2007 Q3 | 138.86 Thousand USD | -6.53% |
2007 Q4 | 121.96 Thousand USD | -12.17% |
2007 FY | 562.07 Thousand USD | -19.67% |
2007 Q1 | 152.66 Thousand USD | -48.46% |
2007 Q2 | 148.57 Thousand USD | -2.68% |
2006 Q3 | 106.29 Thousand USD | -21.37% |
2006 FY | 699.68 Thousand USD | -28.57% |
2006 Q4 | 296.21 Thousand USD | 178.67% |
2006 Q2 | 135.18 Thousand USD | -14.42% |
2006 Q1 | 157.95 Thousand USD | -9.68% |
2005 Q4 | 174.89 Thousand USD | -14.77% |
2005 FY | 979.52 Thousand USD | 85.93% |
2005 Q3 | 205.2 Thousand USD | -57.2% |
2005 Q2 | 479.46 Thousand USD | 265.71% |
2005 Q1 | 131.1 Thousand USD | -9.2% |
2004 Q1 | 118.36 Thousand USD | -18.01% |
2004 FY | 526.83 Thousand USD | 2.14% |
2004 Q2 | 134.44 Thousand USD | 13.59% |
2004 Q3 | 112.18 Thousand USD | -16.56% |
2004 Q4 | 144.38 Thousand USD | 28.7% |
2003 Q4 | 144.36 Thousand USD | -7.83% |
2003 Q3 | 156.62 Thousand USD | 37.11% |
2003 Q2 | 114.23 Thousand USD | 13.57% |
2003 Q1 | 100.58 Thousand USD | -81.9% |
2003 FY | 515.79 Thousand USD | -77.39% |
2002 Q4 | 555.76 Thousand USD | 1245.95% |
2002 FY | 2.28 Million USD | 341.54% |
2002 Q3 | 41.29 Thousand USD | -17.78% |
2002 Q2 | 50.22 Thousand USD | 0.0% |
2001 FY | 516.72 Thousand USD | -96.1% |
2000 FY | 13.23 Million USD | 840426.1% |
1999 FY | 1575.00 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Achiko AG | 6.78 Million USD | 97.793% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 8.04 Million USD | 98.138% |
Cannabis Sativa, Inc. | 862.24 Thousand USD | 82.636% |
CompuMed, Inc. | 2.91 Million USD | 94.868% |
CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 99.985% |
Cogstate Limited | 23.64 Million USD | 99.367% |
CareView Communications, Inc. | 7.21 Million USD | 97.926% |
Craneware plc | 141.35 Million USD | 99.894% |
Caduceus Software Systems Corp. | 2.07 Million USD | 92.799% |
Certive Solutions Inc. | 1.5 Million USD | 90.075% |
Drug Free Solution, Inc. | 1.39 Million USD | 89.273% |
DATATRAK International, Inc. | 3.26 Million USD | 95.419% |
Healixa Inc. | 6.56 Million USD | 97.719% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 3.28 Million USD | 95.436% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | 78.7% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | 491.28 USD | -30376.103% |
IQ-AI Limited | 1.13 Million USD | 86.765% |
Cannabiz Mobile, Inc. | 750.00 USD | -19863.067% |
Mednow Inc. | 2.78 Million USD | 94.621% |
Galileo Life Sciences, Inc. | 270.72 Thousand USD | 44.695% |
MediXall Group, Inc. | 59.26 Thousand USD | -152.62% |
Mitesco, Inc. | 2.58 Million USD | 94.212% |
MobileSmith, Inc. | 8.63 Million USD | 98.267% |
NantHealth, Inc. | 94.47 Million USD | 99.842% |
Net Medical Xpress Solutions, Inc. | 1.76 Million USD | 91.498% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 12.38 Million USD | 98.791% |
Patient Access Solutions, Inc. | 9.19 Million USD | 98.371% |
Pharma-Bio Serv, Inc. | 3.94 Million USD | 96.209% |
PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | -5.933% |
Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -1128.849% |
Renalytix Plc | 29.04 Million USD | 99.484% |
Revium Recovery Inc. | 677 Thousand USD | 77.884% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 369.00 USD | -40475.339% |
Vaso Corporation | 46.39 Million USD | 99.677% |
Vynleads, Inc. | 200.15 Thousand USD | 25.197% |